Reuters logo
BRIEF-Veracyte releases statement on CMS's final 2017 gapfill rate for afirma gene expression classifier
October 1, 2016 / 12:11 AM / a year ago

BRIEF-Veracyte releases statement on CMS's final 2017 gapfill rate for afirma gene expression classifier

Sept 30 (Reuters) - Veracyte Inc :

* Veracyte releases statement on cms’s final 2017 gapfill rate for afirma gene expression classifier

* Believe this new rate is still based on a flawed application of cms gapfill criteria. Plan to file reconsideration request with CMS

Source text for Eikon:

Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below